Clinical Trial Update: Efficacy and Safety of Silfamin for Common Cold [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of Silfamin for the common cold and sore throat has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold
• Sore Throat

Drugs mentioned

• Silfamin

Snippet

Sponsor: Dexa Medica Group | Conditions: Common Cold, Sore-throat | Phase 2 | Status: COMPLETED